المؤلفون: Ott, SR, Bodmann, KF, Grabein, B, Höffken, G, Kolditz, M, Lode, H, Pletz, MW, Thalhammer, F

المصدر: GMS Infectious Diseases; VOL: 8; DOC15 /20200326/

مصطلحات موضوعية: ddc: 610

العلاقة: American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005 Feb;171(4):388-416. DOI:10.1164/rccm.200405-644ST; Bouza E, Burillo A. Advances in the prevention and management of ventilator-associated pneumonia. Curr Opin Infect Dis. 2009 Aug;22(4):345-51. DOI:10.1097/QCO.0b013e32832d8910; Burgess DS, Hall RG 2nd. Simulated comparison of the pharmacodynamics of ciprofloxacin and levofloxacin against Pseudomonas aeruginosa using pharmacokinetic data from healthy volunteers and 2002 minimum inhibitory concentration data. Clin Ther. 2007 Jul;29(7):1421-7. DOI:10.1016/j.clinthera.2007.07.024; Castro-Guardiola A, Viejo-Rodríguez AL, Soler-Simon S, Armengou-Arxé A, Bisbe-Company V, Peñarroja-Matutano G, Bisbe-Company J, García-Bragado F. Efficacy and safety of oral and early-switch therapy for community-acquired pneumonia: a randomized controlled trial. Am J Med. 2001 Oct 1;111(5):367-74. DOI:10.1016/S0002-9343(01) 00868-3; Cazaubon Y, Bourguignon L, Goutelle S, Martin O, Maire P, Ducher M. Are ciprofloxacin dosage regimens adequate for antimicrobial efficacy and prevention of resistance? Pseudomonas aeruginosa bloodstream infection in elderly patients as a simulation case study. Fundam Clin Pharmacol. 2015 Dec;29(6):615-24. DOI:10.1111/fcp.12156; Chalmers JD, Rother C, Salih W, Ewig S. Healthcare-associated pneumonia does not accurately identify potentially resistant pathogens: a systematic review and meta-analysis. Clin Infect Dis. 2014 Feb;58(3):330-9. DOI:10.1093/cid/cit734; Chastre J, Wolff M, Fagon JY, Chevret S, Thomas F, Wermert D, Clementi E, Gonzalez J, Jusserand D, Asfar P, Perrin D, Fieux F, Aubas S; PneumA Trial Group. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA. 2003 Nov;290(19):2588-98. DOI:10.1001/jama.290.19.2588; Cook DJ, Walter SD, Cook RJ, Griffith LE, Guyatt GH, Leasa D, Jaeschke RZ, Brun-Buisson C. Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients. Ann Intern Med. 1998 Sep;129(6):433-40. DOI:10.7326/0003-4819-129-6-199809150-00002; Das D, Le Floch H, Houhou N, Epelboin L, Hausfater P, Khalil A, Ray P, Duval X, Claessens YE, Leport C; ESCAPED Study Group. Viruses detected by systematic multiplex polymerase chain reaction in adults with suspected community-acquired pneumonia attending emergency departments in France. Clin Microbiol Infect. 2015 Jun;21(6):608.e1-8. DOI:10.1016/j.cmi.2015.02.014; Deutsche Gesellschaft für Anästhesiologie und Intensivmedizin; Deutsche Gesellschaft für Infektiologie; Deutsche Gesellschaft für Hygiene und Mikrobiologie; Deutsche Gesellschaft für Pneumologie und Beatmungsmedizin; Paul-Ehrlich Gesellschaft für Chemotherapie; Deutsche Röntgengesellschaft; Gesellschaft für Virologie. S3-Leitlinie Epidemiologie, Diagnostik und Therapie erwachsener Patienten mit nosokomialer Pneumonie. AWMF-Registernummer 020-013. AWMF; 2017. Available from: http://www.awmf.org/leitlinien/detail/ll/020-013.htmlTest; Deutsche Gesellschaft für Pneumologie und Beatmungsmedizin (DGP); Gesellschaft für Pädiatrische Pneumologie (GPP), et al. S3-Leitlinie Lungenerkrankung bei Mukoviszidose. Module 2: Diagnostik und Therapie bei der chronischen Infektion mit Pseudomonas aeruginosa. Registernummer 020-018. AWMF; 2017. Available from: http://www.awmf.org/uploads/tx_szleitlinien/020-018l_S3_Mukoviszidose_Modul_2_2017-08-01.pdfTest; de With K, Allerberger F, Amann S, Apfalter P, Brodt HR, Eckmanns T, Fellhauer M, Geiss HK, Janata O, Krause R, Lemmen S, Meyer E, Mittermayer H, Porsche U, Presterl E, Reuter S, Sinha B, Strauß R, Wechsler-Fördös A, Wenisch C, Kern WV. Strategies to enhance rational use of antibiotics in hospital: a guideline by the German Society for Infectious Diseases. Infection. 2016; 44(3):395-439. DOI:10.1007/s15010-016-0885-z; Ewig S, Höffken G, Kern WV, Rohde G, Flick H, Krause R, Ott S, Bauer T, Dalhoff K, Gatermann S, Kolditz M, Krüger S, Lorenz J, Pletz M, de Roux A, Schaaf B, Schaberg T, Schütte H, Welte T. Behandlung von erwachsenen Patienten mit ambulant erworbener Pneumonie und Prävention - Update 2016 [Management of Adult Community-acquired Pneumonia and Prevention - Update 2016]. Pneumologie. 2016 Mar;70(3):151-200. DOI:10.1055/s-0042-101873; Ewig S, Welte T, Chastre J, Torres A. Rethinking the concepts of community-acquired and health-care-associated pneumonia. Lancet Infect Dis. 2010 Apr;10(4):279-87. DOI:10.1016/S1473-3099(10) 70032-3; Ewig S. The Pneumonia Triad. Eur Respir Monogr. 2014;63:13-24.; Fink MP, Snydman DR, Niederman MS, Leeper KV Jr, Johnson RH, Heard SO, Wunderink RG, Caldwell JW, Schentag JJ, Siami GA. Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. The Severe Pneumonia Study Group. Antimicrob Agents Chemother. 1994 Mar;38(3):547-57. DOI:10.1128/AAC.38.3.547; Haeseker M, Stolk L, Nieman F, Hoebe C, Neef C, Bruggeman C, Verbon A. The ciprofloxacin target AUC: MIC ratio is not reached in hospitalized patients with the recommended dosing regimens. Br J Clin Pharmacol. 2013 Jan;75(1):180-5. DOI:10.1111/j.1365-2125.2012.04337.x; Heyland DK, Dodek P, Muscedere J, Day A, Cook D; Canadian Critical Care Trials Group. Randomized trial of combination versus monotherapy for the empiric treatment of suspected ventilator-associated pneumonia. Crit Care Med. 2008 Mar;36(3):737-44. DOI:10.1097/01.CCM.0B013E31816203D6; Ibrahim EH, Tracy L, Hill C, Fraser VJ, Kollef MH. The occurrence of ventilator-associated pneumonia in a community hospital: risk factors and clinical outcomes. Chest. 2001 Aug;120(2):555-61. DOI:10.1378/chest.120.2.555; Jain S, Self WH, Wunderink RG; CDC EPIC Study Team. Community-Acquired Pneumonia Requiring Hospitalization. N Engl J Med. 2015 Dec;373(24):2382. DOI:10.1056/NEJMc1511751; Jung YJ, Koh Y, Hong SB, Chung JW, Ho Choi S, Kim NJ, Kim MN, Choi IS, Han SY, Kim WD, Yun SC, Lim CM. Effect of vancomycin plus rifampicin in the treatment of nosocomial methicillin-resistant Staphylococcus aureus pneumonia. Crit Care Med. 2010 Jan;38(1):175-80.; Khachman D, Conil JM, Georges B, Saivin S, Houin G, Toutain PL, Laffont CM. Optimizing ciprofloxacin dosing in intensive care unit patients through the use of population pharmacokinetic-pharmacodynamic analysis and Monte Carlo simulations. J Antimicrob Chemother. 2011 Aug;66(8):1798-809. DOI:10.1093/jac/dkr220; Kolditz M, Ewig S, Klapdor B, Schütte H, Winning J, Rupp J, Suttorp N, Welte T, Rohde G; CAPNETZ study group. Community-acquired pneumonia as medical emergency: predictors of early deterioration. Thorax. 2015; 70(6):551-8. DOI:10.1136/thoraxjnl-2014-206744; Kolditz M, Ewig S, Schütte H, Suttorp N, Welte T, Rohde G; CAPNETZ study group. Assessment of oxygenation and comorbidities improves outcome prediction in patients with community-acquired pneumonia with a low CRB-65 score. J Intern Med. 2015 Aug;278(2):193-202. DOI:10.1111/joim.12349; Kresken M, Grabein B, Becker K, Straube E, Wichelhaus TA, Willinger B. Kalkulierte parenterale Initialtherapie bakterieller Infektionen: Mikrobiologie [Calculated parenteral initial treatment of bacterial infections: Microbiology]. GMS Infect Dis. 2020;7:Doc18. DOI:10.3205/id000062; Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, Suppes R, Feinstein D, Zanotti S, Taiberg L, Gurka D, Kumar A, Cheang M. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006; 34(6):1589-96. DOI:10.1097/01.CCM.0000217961.75225.E9; Lode H. Role of sultamicillin and ampicillin/sulbactam in the treatment of upper and lower bacterial respiratory tract infections. Int J Antimicrob Agents. 2001 Sep;18(3):199-209. DOI:10.1016/S0924-8579(01) 00387-9; Lorenz J, Bodmann KF, Bauer TT, Ewig S, Trautmann M, Vogel F; German Society for Anesthesiology and Intensive Care (DGAI). Nosokomiale Pneumonie: Prävention, Diagnostik und Therapie - Ein Konsensuspapier der Deutschen Gesellschaft für Pneumologie (DGP) und der Paul-Ehrlich-Gesellschaft für Chemotherapie (PEG) unter Mitarbeit von Experten der Deutschen Gesellschaft für Anästhesiologie und Intensivmedizin (DGAI) [Nosocomial pneumonia: prevention, diagnosis, treatment]. Pneumologie. 2003 Sep;57(9):532-45. DOI:10.1055/s-2003-42217; Ott SR, Allewelt M, Lorenz J, Reimnitz P, Lode H; German Lung Abscess Study Group. Moxifloxacin vs ampicillin/sulbactam in aspiration pneumonia and primary lung abscess. Infection. 2008 Feb;36(1):23-30. DOI:10.1007/s15010-007-7043-6; Patterson JE. Antibiotic utilization: is there an effect on antimicrobial resistance? Chest. 2001 Feb;119(2 Suppl):426S-30S. DOI:10.1378/chest.119.2_suppl.426S; Pletz MW, Bloos F, Burkhardt O, Brunkhorst FM, Bode-Böger SM, Martens-Lobenhoffer J, Greer MW, Stass H, Welte T. Pharmacokinetics of moxifloxacin in patients with severe sepsis or septic shock. Intensive Care Med. 2010; 36(6):979-83. DOI:10.1007/s00134-010-1864-y; Polverino E, Goeminne PC, McDonnell MJ, Aliberti S, Marshall SE, Loebinger MR, Murris M, Cantón R, Torres A, Dimakou K, De Soyza A, Hill AT, Haworth CS, Vendrell M, Ringshausen FC, Subotic D, Wilson R, Vilaró J, Stallberg B, Welte T, Rohde G, Blasi F, Elborn S, Almagro M, Timothy A, Ruddy T, Tonia T, Rigau D, Chalmers JD. European Respiratory Society guidelines for the management of adult bronchiectasis. Eur Respir J. 2017 Sep 9;50(3). pii: 1700629. DOI:10.1183/13993003.00629-2017; Rello J, Vidaur L, Sandiumenge A, Rodríguez A, Gualis B, Boque C, Diaz E. De-escalation therapy in ventilator-associated pneumonia. Crit Care Med. 2004 Nov;32(11):2183-90. DOI:10.1097/01.CCM.0000145997.10438.28; Roberts JA, Paul SK, Akova M, Bassetti M, De Waele JJ, Dimopoulos G, Kaukonen KM, Koulenti D, Martin C, Montravers P, Rello J, Rhodes A, Starr T, Wallis SC, Lipman J. Reply to Rhodes et al. Clin Infect Dis. 2014 Sep;59(6):907-8. DOI:10.1093/cid/ciu403; Schack M, Sachse S, Rödel J, Frangoulidis D, Pletz MW, Rohde GU, Straube E, Boden K. Coxiella burnetii (Q fever) as a cause of community-acquired pneumonia during the warm season in Germany. Epidemiol Infect. 2014 Sep;142(9):1905-10. DOI:10.1017/S0950268813002914; Schünemann HJ, Jaeschke R, Cook DJ, Bria WF, El-Solh AA, Ernst A, Fahy BF, Gould MK, Horan KL, Krishnan JA, Manthous CA, Maurer JR, McNicholas WT, Oxman AD, Rubenfeld G, Turino GM, Guyatt G; ATS Documents Development and Implementation Committee. An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. Am J Respir Crit Care Med. 2006 Sep 1;174(5):605-14. DOI:10.1164/rccm.200602-197ST; Self WH, Williams DJ, Zhu Y, Ampofo K, Pavia AT, Chappell JD, Hymas WC, Stockmann C, Bramley AM, Schneider E, Erdman D, Finelli L, Jain S, Edwards KM, Grijalva CG. Respiratory Viral Detection in Children and Adults: Comparing Asymptomatic Controls and Patients With Community-Acquired Pneumonia. J Infect Dis. 2016 Feb;213(4):584-91. DOI:10.1093/infdis/jiv323; Torres A, Ewig S, Lode H, Carlet J; European HAP working group. Defining, treating and preventing hospital acquired pneumonia: European perspective. Intensive Care Med. 2009 Jan;35(1):9-29. DOI:10.1007/s00134-008-1336-9; Valencia M, Torres A. Ventilator-associated pneumonia. Curr Opin Crit Care. 2009 Feb;15(1):30-5. DOI:10.1097/MCC.0b013e3283220e78; West M, Boulanger BR, Fogarty C, Tennenberg A, Wiesinger B, Oross M, Wu SC, Fowler C, Morgan N, Kahn JB. Levofloxacin compared with imipenem/cilastatin followed by ciprofloxacin in adult patients with nosocomial pneumonia: a multicenter, prospective, randomized, open-label study. Clin Ther. 2003 Feb;25(2):485-506. DOI:10.1016/S0149-2918(03) 80091-7; Wilke M, Grube RF, Bodmann KF. Guideline-adherent initial intravenous antibiotic therapy for hospital-acquired/ventilator-associated pneumonia is clinically superior, saves lives and is cheaper than non guideline adherent therapy. Eur J Med Res. 2011 Jul;16(7):315-23.; Wunderink RG, Rello J, Cammarata SK, Croos-Dabrera RV, Kollef MH. Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia. Chest. 2003 Nov;124(5):1789-97. DOI:10.1016/S0012-3692(15) 33412-7; Wunderink RG, Niederman MS, Kollef MH, Shorr AF, Kunkel MJ, Baruch A, McGee WT, Reisman A, Chastre J. Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study. Clin Infect Dis. 2012 Mar;54(5):621-9. DOI:10.1093/cid/cir895; Wunderink RG, Mendelson MH, Somero MS, Fabian TC, May AK, Bhattacharyya H, Leeper KV Jr, Solomkin JS. Early microbiological response to linezolid vs vancomycin in ventilator-associated pneumonia due to methicillin-resistant Staphylococcus aureus. Chest. 2008 Dec;134(6):1200-7. DOI:10.1378/chest.08-0011; http://dx.doi.org/10.3205/id000059Test; http://nbn-resolving.de/urn:nbn:de:0183-id0000594Test; http://www.egms.de/en/journals/id/2020-8/id000059.shtmlTest

الإتاحة: https://doi.org/10.3205/id000059Test
https://doi.org/10.1164/rccm.200405-644STTest
https://doi.org/10.1097/QCO.0b013e32832d8910Test
https://doi.org/10.1016/j.clinthera.2007.07.024Test
https://doi.org/10.1016/S0002-9343Test(01
https://doi.org/10.1093/cid/cit734Test
https://doi.org/10.1001/jama.290.19.2588Test
https://doi.org/10.7326/0003-4819-129-6-199809150-00002Test
https://doi.org/10.1016/j.cmi.2015.02.014Test
https://doi.org/10.1007/s15010-016-0885-zTest

المؤلفون: Kolditz, M., Höffken, G.

المصدر: Der Pneumologe; 20240101, Issue: Preprints p1-8, 8p

المؤلفون: Schuette W, Schneider CP, Engel-Riedel W, Schumann C, Kohlhaeufl M, Serke MHU, Hoeffken G, Kortsik C, Reck M

المصدر: Lung Cancer: Targets and Therapy, Vol Volume 8, Pp 217-229 (2017)

مصطلحات موضوعية: Bevacizumab, Pemetrexed, Carboplatin, NSCLC, elderly patients, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

العلاقة: https://www.dovepress.com/65plus-open-label-study-of-bevacizumab-in-combination-with-pemetrexed--peer-reviewed-article-LCTTTest; https://doaj.org/toc/1179-2728Test; https://doaj.org/article/8e3db1b2c04f43a2889c3dfb42a65184Test

الإتاحة: https://doaj.org/article/8e3db1b2c04f43a2889c3dfb42a65184Test

المؤلفون: Jensen, Andreas Vestergaard, Faurholt-Jepsen, Daniel, Egelund, Gertrud Baunbæk, Andersen, Stine Bang, Petersen, Pelle Trier, Benfield, Thomas, Witzenrath, Martin, Rohde, Gernot, Ravn, Pernille, Dreher, M, Cornelissen, C, Knüppel, W, Stolz, D, Suttorp, N, Creutz, P, Bauer, T, Sabha, T, Pankow, W, Lies, A, Thiemig, D, Hauptmeier, B, Ewig, S, Wehde, D, Prediger, M, Schmager, S, Höffken, G, Kolditz, M, Schulte-Hubbert, B, Langner, S, Welte, T, Barten, G, Abrahamczik, M, Naim, J, Kröner, W, Illig, T, Klopp, N, Kroegel, C, Pletz, M, Happe, J, Frosinski, J, Winning, J, Moeser, A, Dalhoff, K, Dageförde, K, Franzen, K, Hyzy, F, Schmieg, H, Parschke, P, Thiemann, P, Ahrens, J

المصدر: Clinical Infectious Diseases ; volume 65, issue 12, page 2091-2098 ; ISSN 1058-4838 1537-6591

الإتاحة: https://doi.org/10.1093/cid/cix703Test
http://academic.oup.com/cid/article-pdf/65/12/2091/21968078/cix703.pdfTest

المؤلفون: Sadushi-Kolici, R., Jansa, P., Kopec, G., Torbicki, A., Campean, I.A., Hoeffken, G., Skoro-Sajer, N., Simkova, I., Karlocai, K., Steringer-Mascherbauer, R., Samarzija, M., Salobir, B., Klepetko, W., Lindner, J., Lang, I.M.

المصدر: European Heart Journal ; volume 38, issue suppl_1 ; ISSN 0195-668X 1522-9645

مصطلحات موضوعية: Cardiology and Cardiovascular Medicine

الإتاحة: https://doi.org/10.1093/eurheartj/ehx493.5017Test
http://academic.oup.com/eurheartj/article-pdf/38/suppl_1/ehx493.5017/19615401/ehx493.5017.pdfTest

المؤلفون: Kolditz, M, Tesch, F, Mocke, L, Höffken, G, Ewig, S, Schmitt, J

المصدر: Pneumologie ; volume 70, issue 12, page 826-830 ; ISSN 0934-8387 1438-8790

الإتاحة: https://doi.org/10.1055/s-0036-1596071Test

المؤلفون: Wirtz, H.R., Lang, S., Mezger, J., Hammerschmidt, S., Gaska, T., Lerchenmueller, C., Reck, M., Haas, S., Reichert, D., Hoeffken, G.

المصدر: Annals of Oncology ; volume 27, page vi442 ; ISSN 0923-7534

مصطلحات موضوعية: Oncology, Hematology

الإتاحة: https://doi.org/10.1093/annonc/mdw383.77Test
https://api.elsevier.com/content/article/PII:S0923753419449004?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S0923753419449004?httpAccept=text/plainTest
http://academic.oup.com/annonc/article-pdf/27/suppl_6/1277P/19451608/mdw383.77.pdfTest

المؤلفون: Braun, S.D., Platzek, I., Danowski, D., Zöphel, K., Weise, M., Kolditz, M., Katzke, S., Strasser, R.H., Höffken, G., Halank, M.

المصدر: Heart, Lung and Circulation ; volume 25, issue 12, page 1154-1163 ; ISSN 1443-9506

مصطلحات موضوعية: Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine

الإتاحة: https://doi.org/10.1016/j.hlc.2016.04.023Test
https://api.elsevier.com/content/article/PII:S1443950616302499?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S1443950616302499?httpAccept=text/plainTest

المؤلفون: Höffken, G

المصدر: Infektiologie Update 2014; 24. Jahrestagung der Paul-Ehrlich-Gesellschaft für Chemotherapie (PEG); 20141016-20141018; Weimar; DOC14peg13 /20141002/

مصطلحات موضوعية: ddc: 610

العلاقة: Bogaert D, van Belkum A, Sluijter M, Luijendijk A, de Groot R, Rümke HC, Verbrugh HA, Hermans PW. Colonisation by Streptococcus pneumoniae and Staphylococcus aureus in healthy children. Lancet. 2004 Jun 5;363(9424):1871-2. DOI:10.1016/S0140-6736(04)16357-5; Dagan R, Melamed R, Muallem M, Piglansky L, Greenberg D, Abramson O, Mendelman PM, Bohidar N, Yagupsky P. Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine. J Infect Dis. 1996 Dec;174(6):1271-8. DOI:10.1093/infdis/174.6.1271; http://dx.doi.org/10.3205/14peg13Test; http://nbn-resolving.de/urn:nbn:de:0183-14peg134Test; http://www.egms.de/en/meetings/peg2014/14peg13.shtmlTest

الإتاحة: https://doi.org/10.3205/14peg13Test
https://doi.org/10.1016/S0140-6736Test(04)16357-5
https://doi.org/10.1093/infdis/174.6.1271Test
http://nbn-resolving.de/urn:nbn:de:0183-14peg134Test
http://www.egms.de/en/meetings/peg2014/14peg13.shtmlTest

المؤلفون: Throne, T, Junghanß, S, Peschke, A, Kolditz, M, Höffken, G, Koschel, D

المصدر: 21. Herbsttagung der Mitteldeutschen Gesellschaft für Pneumologie und Thoraxchirurgie ; Pneumologie ; ISSN 1438-8790

الإتاحة: https://doi.org/10.1055/s-0039-3401409Test